Evidence map›Paper›PMID 40093796›Full record

ArticleInternational journal of medical sciences2025

The Role of Mesenchymal Stem Cells in Treating Diabetic Kidney Disease: Immunomodulatory Effects and Kidney Regeneration.

Po-Jen Hsiao, Wen-Yi Kao, Li-Chin Sung, Chia-Yi Lin, Liam Li-An Tsou, Yung-Hsi Kao, Chu-Lin Chou, Kung-Ta Lee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Po-Jen HsiaoDivision of Nephrology, Department of Internal Medicine, Taoyuan Armed Forces General Hospital, Taoyuan, Taiwan.
Wen-Yi KaoDepartment of Biochemical Science and Technology, National Taiwan University, Taipei, Taiwan.
Li-Chin SungDivision of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
Chia-Yi LinDivision of Cardiology, Department of Internal Medicine, Tri-Service General Hospital, Taipei, Taiwan.
Liam Li-An TsouNephrology Division, Department of Medicine, Mount Sinai Hospital, New York, NY, USA.
Yung-Hsi KaoDepartment of Life Sciences, National Central University, Taoyuan, Taiwan.
Chu-Lin ChouTaipei Medical University-Research Centre of Urology and Kidney, Taipei Medical University, Taipei, Taiwan.
Kung-Ta LeeDepartment of Biochemical Science and Technology, National Taiwan University, Taipei, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, ExperimentalDiabetic NephropathiesMesenchymal Stem CellsMesenchymal Stem Cell TransplantationAnimalsCytokinesDiabetes Mellitus, Type 1Disease Models, AnimalHumansImmunomodulationKidneyMaleMiceRegenerationStreptozocinUmbilical CordCytokinesStreptozocindiabetic kidney diseasediabetic nephropathyimmunomodulationimmunomodulatory effectskidney regenerationmesenchymal stem cells

Identifiers

PMID40093796
PMCPMC11905258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.